| NCLEX | NRGEX | NCLEX / NRGEX | |
| Total Expense Ratio | 0.85 | 0.03 | 2,833% |
| Annual Report Gross Expense Ratio | 0.85 | 0.69 | 123% |
| Fund Existence | 39 years | 4 years | - |
| Gain YTD | -12.001 | -4.609 | 260% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 406M | 8.43B | 5% |
| Annual Yield % from dividends | 0.00 | 0.55 | - |
| Returns for 1 year | -18.05 | -13.79 | 131% |
| Returns for 3 years | -0.22 | 0.06 | -370% |
| Returns for 5 years | -14.67 | N/A | - |
| Returns for 10 years | 5.94 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TGVAX | 32.87 | 0.04 | +0.12% |
| Thornburg International Equity A | |||
| LIDOX | 10.19 | -0.09 | -0.88% |
| Lord Abbett International Value F3 | |||
| CWMEX | 66.02 | -0.94 | -1.40% |
| American Funds Washington Mutual 529E | |||
| TMIRX | 10.32 | -0.26 | -2.46% |
| Transamerica Mid Cap Growth R | |||
| GSMQX | 19.28 | -0.64 | -3.21% |
| Goldman Sachs Small/Mid Cap Growth Svc | |||